Clinical studyLipid metabolism and apolipoprotein E phenotypes in patients with xanthelasma
References (31)
The pathogenesis and clinical significance of xanthelasma palpebrarum
J Am Acad Dermatol
(1994)- et al.
Serum lipids, lipoprotein lipids and coronary heart disease in patients with xanthelasma palpebrarum
Atherosclerosis
(1981) Xanthelasma and hyperlipoproteinaemia
Clin Chim Acta
(1976)- et al.
Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure
J Lipid Res
(1982) - et al.
Determination of B protein of low density lipoprotein directly in plasma
J Lipid Res
(1975) - et al.
Reduced HDL2 levels in myocardial infarction patients without risk factors for atherosclerosis
Atherosclerosis
(1987) Lipoprotein physiology and its relationship to atherogenesis
Endocrinol Metab Clin North Am
(1990)- et al.
Xanthelasma et dyslipoprotéinémie: présentation de deux études retrospectives
Ann Dermatol Venereol (Paris)
(1982) - et al.
The association of dyslipoproteinemia with corneal arcus and xanthelasma
Circulation
(1986) - et al.
Apolipoprotein E phenotipes, lipoprotein composition, and xanthelasmas
Arch Dermatol
(1988)
Dyslipoproteinemia in patients with xanthelasma
Arch Dermatol
(1989)
Xanthelasma: clinical indicator of decreased levels of high-density lipoprotein cholesterol
South Med J
(1989)
Dyslipoproteinemia in patients with xanthelasma
Arch Dermatol
(1989)
Xanthelasma palpebrarum
JAMA
(1965)
Clinical observations regarding xanthelasma
Ann Intern Med
(1959)
Cited by (0)
Copyright © 1995 Published by Excerpta Medica Inc.